-
公开(公告)号:US09726672B2
公开(公告)日:2017-08-08
申请号:US15166514
申请日:2016-05-27
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
IPC: G01N33/68 , G01N33/566 , G01N33/94
CPC classification number: G01N33/6854 , G01N33/558 , G01N33/566 , G01N33/94 , G01N2333/70546 , G01N2333/7055 , G01N2800/26 , G01N2800/52
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
-
公开(公告)号:US20250164486A1
公开(公告)日:2025-05-22
申请号:US18809113
申请日:2024-08-19
Applicant: Biogen MA Inc.
Inventor: Gary Lewis Bloomgren , Carmen Bozic , Sophia Lee , Meena Subramanyam , Tatiana Plavina
IPC: G01N33/569
Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).
-
公开(公告)号:US12066442B2
公开(公告)日:2024-08-20
申请号:US17393335
申请日:2021-08-03
Applicant: Biogen MA Inc.
Inventor: Gary Lewis Bloomgren , Carmen Bozic , Sophia Lee , Meena Subramanyam , Tatiana Plavina
IPC: G01N33/569
CPC classification number: G01N33/56983 , C12N2710/22011 , G01N2333/025 , G01N2469/20 , G01N2800/28 , G01N2800/2814 , G01N2800/50 , G01N2800/52
Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).
-
公开(公告)号:US20220357338A1
公开(公告)日:2022-11-10
申请号:US17700242
申请日:2022-03-21
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
IPC: G01N33/68 , G01N33/558 , G01N33/566 , G01N33/94
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
-
公开(公告)号:US10955422B2
公开(公告)日:2021-03-23
申请号:US15120573
申请日:2015-02-27
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , John P. Carulli , Leonid Gorelik , Teresa Compton
IPC: G01N33/53 , G01N33/68 , C12Q1/6883
Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive Multifocal Leukoencephalopathy (PML).
-
公开(公告)号:US20200088738A1
公开(公告)日:2020-03-19
申请号:US16422822
申请日:2019-05-24
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
IPC: G01N33/68 , G01N33/94 , G01N33/566 , G01N33/558
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
-
公开(公告)号:US20180143204A1
公开(公告)日:2018-05-24
申请号:US15637446
申请日:2017-06-29
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
IPC: G01N33/68 , G01N33/566 , G01N33/94
CPC classification number: G01N33/6854 , G01N33/558 , G01N33/566 , G01N33/94 , G01N2333/70546 , G01N2333/7055 , G01N2800/26 , G01N2800/52
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
-
公开(公告)号:US20190227064A1
公开(公告)日:2019-07-25
申请号:US16211154
申请日:2018-12-05
Applicant: BIOGEN MA INC.
Inventor: Gary Lewis Bloomgren , Carmen Bozic , Sophia Lee , Meena Subramanyam , Tatiana Plavina
IPC: G01N33/569
Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).
-
公开(公告)号:US10302654B2
公开(公告)日:2019-05-28
申请号:US15637446
申请日:2017-06-29
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
IPC: G01N33/68 , G01N33/566 , G01N33/94 , G01N33/558
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
-
公开(公告)号:US20160274125A1
公开(公告)日:2016-09-22
申请号:US15166514
申请日:2016-05-27
Applicant: Biogen MA Inc.
Inventor: Tatiana Plavina , Paula S. Hochman , Michaela Lerner
CPC classification number: G01N33/6854 , G01N33/558 , G01N33/566 , G01N33/94 , G01N2333/70546 , G01N2333/7055 , G01N2800/26 , G01N2800/52
Abstract: Methods and apparatus for assaying the level of analytes in a sample, related to VLA-4, are disclosed. A method of decreasing the level of an anti-integrin antibody in a subject is described including a) contacting a biological sample from a subject with a detectable capture agent associated with a substrate, wherein the capture agent can bind an anti-integrin antibody in the sample; b) detecting binding of the capture agent with the level of the anti-integrin antibody; and c) treating the subject with plasma exchange until the level of the anti-integrin antibody in the sample reaches a predetermined level.
Abstract translation: 公开了用于测定与VLA-4相关的样品中分析物水平的方法和装置。 描述了降低受试者中抗整联蛋白抗体水平的方法,其包括:a)将来自受试者的生物样品与与底物相关的可检测的捕获剂接触,其中所述捕获剂可以结合抗 - 整联蛋白抗体 样品; b)检测捕获剂与抗整联蛋白抗体水平的结合; 和c)用血浆置换治疗受试者,直到样品中抗整联蛋白抗体的水平达到预定水平。
-
-
-
-
-
-
-
-
-